Description

Part redemption of debentures with reduced face value from Rs. 100,000 to Rs. 80,952 per debenture, effective October 10, 2025.

Summary

OXYZO FINANCIAL SERVICES LIMITED has announced part redemption of its 9.75% Non-Convertible Debentures maturing on March 27, 2027 (ISIN: INE04VS07388). The record date is October 12, 2025, and trading will commence with reduced face value effective October 10, 2025 in settlement DR-733/2025-2026.

Key Points

  • ISIN: INE04VS07388 (BSE Code: 976577)
  • Coupon Rate: 9.75%
  • Maturity Date: March 27, 2027
  • Record Date: October 12, 2025
  • Original Face Value: Rs. 100,000 per debenture (implied)
  • Reduced Face Value: Rs. 80,952 per debenture
  • Redemption Amount: Rs. 19,048 per debenture (19.048% partial redemption)
  • Effective Date for Reduced Face Value Trading: October 10, 2025
  • Settlement Number: DR-733/2025-2026

Regulatory Changes

No regulatory changes. This is a standard corporate action under existing debt securities framework.

Compliance Requirements

  • Trading members must note the reduced face value effective October 10, 2025
  • All trades from October 10, 2025 onwards must reflect the new face value of Rs. 80,952 per debenture
  • Interest calculations going forward will be based on the reduced face value

Important Dates

  • October 8, 2025: Notice date
  • October 10, 2025: Effective date for trading with reduced face value (Settlement DR-733/2025-2026)
  • October 12, 2025: Record date for part redemption and interest payment

Impact Assessment

This part redemption affects holders of OXYZO FINANCIAL SERVICES LIMITED’s privately placed debentures. Debenture holders as of the record date will receive approximately 19% of their principal back along with accrued interest. The reduced face value will lower future interest payments proportionally. This is a routine debt servicing activity with limited broader market impact, affecting only specific institutional investors holding these privately placed securities.

Impact Justification

Routine corporate action affecting specific debenture holders with part redemption reducing face value by approximately 19%